Dr. Galvez shows how lunasin the world's first epigenetic superfood affects multiple genes in multiple pathways versus cancer drugs.

1. Lunasin and Nutritional
Epigenetics
"No other company is advancing the field of epigenetics like Reliv.We
are in the middle of a revolution in nutrition, and we are all witnesses."
Dr. Alfredo Galvez, the Center of Excellence in Nutritional
Genomics at University of California - Davis.

2. What makes lunasin different from cancer drugs?
“Cancer drugs, like tamoxifen for example, target a specific gene (ER-estrogen
receptor) and a specific physiological pathway (estrogen receptor pathway) in
stopping cancer development. Lunasin, as a low potency dietary ingredient,
has been shown in a number of publications to affect multiple genes in
multiple pathways, albeit in incremental fashion, to help prevent cancer
development.” Dr. Galvez
View how lunasin affects multiple genes in multiple pathways

3. Conventional Drug Development
From Hanahan and Weinberg, 2000 Cell 100:50-57

4. Conventional Drug Development
From Hanahan and Weinberg, 2000 Cell 100:50-57

5. PP2
PI3K
Conventional Drug Development
From Hanahan and Weinberg, 2000 Cell 100:50-57

6. PP2
PI3K
Conventional Drug Development
From Hanahan and Weinberg, 2000 Cell 100:50-57

7. PP2
PI3K
chloroquine
Conventional Drug Development
From Hanahan and Weinberg, 2000 Cell 100:50-57

8. Lunasin as a dietary ingredient prevents disease
formation by affecting multiple pathways

9. Akt
Bcl2
Bcl2
Ras
Lunasin as a dietary ingredient prevents disease
formation by affecting multiple pathways
α5β3
NF-κB
Lunasin inhibits oncogene
and carcinogen-induced
cell transformation.

10. p53
Akt
Bcl2
Bcl2caspase
Bad
Ras
Lunasin as a dietary ingredient prevents disease
formation by affecting multiple pathways
Rb
α5β3
NF-κB
p21
Pten
Lunasin inhibits oncogene
and carcinogen-induced
cell transformation.
Lunasin increases expression
of genes associated with
tumor suppression,
apoptosis, mitotic control
and DNA repair.
pp32

11. p53
Akt
Bcl2
Bcl2caspase
Bad
Ras
Lunasin as a dietary ingredient prevents disease
formation by affecting multiple pathways
Rb
α5β3
NF-κB
p21
Pten
Lunasin inhibits oncogene
and carcinogen-induced
cell transformation.
Lunasin increases expression
of genes associated with
tumor suppression,
apoptosis, mitotic control
and DNA repair.
pp32
Tamoxifen chemopreventive
drug inhibits estrogen
receptor (ER)
ER

12. LunaRich: Nutrition at a Higher Level
What is it? LunaRich® from Reliv is a breakthrough nutritional ingredient that
optimizes bioactive lunasin more than anything else available today and we
have the exclusive rights.
Take control of your health - Order Today: WealthThruNutrition.com